Skip to main content

Table 1 Sample availability for k13 genotyping

From: Lack of K13 mutations in Plasmodium falciparum persisting after artemisinin combination therapy treatment of Kenyan children

Sample ID

D0

D1

D2

D3

D28

D42

K0025

X

    

X

K0344

X

    

X

K0385

X

    

X

K0544

X

    

X

K0598

X

   

X

 

K0701

X

  

X

 

X

K0719

X

  

X

 

X

K0774

X

    

X

K0804

X

    

X

K0840

X

   

X

 

K0875

X

    

X

K0881

X

    

X

K1010

X

    

X

K1149

X

  

X

 

X

K1152

X

   

X

 

K1307

X

   

X

 

K1348

X

  

X

 

X

K1368

X

X

X

X

 

X

K1438

X

  

X

 

X

K1478

X

   

X

 

K1521

X

    

X

K1861

X

  

X

 

X

K1917

X

   

X

 

K1943

X

    

X

K2023

X

    

X

K2024

X

    

X

K3077

X

    

X

K3212

X

  

X

X

 

K3215

X

  

X

 

X

K3404

X

  

X

X

 

K3762

X

   

X

 

K3801

X

   

X

 
  1. Table shows sample which were available for k13 genotyping on different time points. Days 0 and day of fail (days 28 or 42) samples were available for k13 genotyping for 32 patients. Of the 32, ten patients had additional samples on day 3 while for patient K3168, additional samples on days 1 and 2 were included retrospectively for further k13 genotype analysis